RAPID RESPONSE: Exploring the Changes Hidden in the August 3, 2020 Final USPTO Fee Rules
October 15, 2020 12:30 PM to 2:00 PM
Exploring the Changes Hidden in the August 3, 2020 Final USPTO Fee Rules
The USPTO published a Final Rule for "Setting and Adjusting Patent Fees During Fiscal Year 2020" on August 3, 2020, in a Federal Register Notice, announcing fee changes that take effect October 2, 2020. However, the Final Rule contained more than just the usual fee raises. The Final Rule established three other important changes for patent practitioners that could be missed without a careful review, and went largely unnoticed by the patent community. This webinar will provide information about these changes that take effect starting in 2022, including a non-DOCX filing surcharge, a new biennial patent practitioner registration statement requirement, and a voluntary CLE certification for registered practitioners. Speakers will explore the details outlined in the August 3 Final Rule, details that still need clarification by the USPTO, and potential implications for patent applicants and practitioners.
Moderator:
Brian Stanton, Stanton Consulting Services
Speakers:
Terry Clark, Bass, Berry & Sims – Biennial Registration Statement
Theresa Stadheim, Mueting Raasch Group – Voluntary CLE Certification
Brad Forrest, Schwegman Lundberg & Woessner, P.A. – Non-DOCX Filing Surcharge
Add to:
News
-
AIPLA Comments to the Copyright Office on Alternative Fee Structures for Registration
July 6, 2026
Alexandria, VA. June 24, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments on the U.S. Copyright Office's Notice of Inquiry regarding alternative copyright registration fee structures. -
AIPLA Comments to the Copyright Office on Group Registration of Updates to a News Website
July 6, 2026
Alexandria, VA. June 29, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments supporting the U.S. Copyright Office's proposed expansion of eligibility for group registration of updates to news websites by removing restrictions that exclude subject-specific publications. -
AIPLA Submits Comments on the World Intellectual Property Organization Riyadh Design Law Treaty
June 24, 2026
Alexandria, VA. June 11, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments on the World Intellectual Property Organization Riyadh Design Law Treaty. -
AIPLA Files Amicus Brief in Arbutus Biopharma Corp. v. Moderna, Inc.
June 22, 2026
Arlington, VA. June 5, 2026 – The American Intellectual Property Law Association (AIPLA) filed an amicus brief in Arbutus Biopharma Corp. v. Modernatx, Inc. -
Supreme Court Issues Unanimous Decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.
June 4, 2026
On June 4, 2026, the Supreme Court issued a unanimous decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. While the Court reaffirmed existing law on pleading standards, it reversed the Federal Circuit’s decision that had focused on how relevant statements could be understood by medical providers as instructions to infringe. The amicus brief filed by AIPLA on March 27, 2026, advocated for affirmance and cautioned the Court not to change the patent infringement pleading standard or adopt any categorical exemption from inducement for a particular industry.
